Abagovomab
Abagovomab is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tumour antigen (CA-125) highly expressed in the epithelial ovarian cancer. Abagovomab does not bind directly to CA-125, but it works as a "surrogate" antigen, enabling the immune system to identify and attack tumour cells displaying the CA-125 protein. Through this, it is hoped that the body's immune system may be able to combat any remaining individual tumour cells and thus prevent recurrence of the disease.
primaryTopic
Abagovomab
Abagovomab is a mouse anti-idiotype monoclonal antibody whose variable epitope mirrors a tumour antigen (CA-125) highly expressed in the epithelial ovarian cancer. Abagovomab does not bind directly to CA-125, but it works as a "surrogate" antigen, enabling the immune system to identify and attack tumour cells displaying the CA-125 protein. Through this, it is hoped that the body's immune system may be able to combat any remaining individual tumour cells and thus prevent recurrence of the disease.
has abstract
Abagovomab is a mouse anti-idi ...... ent recurrence of the disease.
@en
L'abagovomab è un anticorpo mo ...... ci a base di platino e taxani.
@it
أباغوفوماب هو جسم مضاد وحيد ال ...... قليل نمو هذا النوع من السرطان.
@ar
ATC prefix
CAS number
792921-10-9
FDA UNII code
3YK0326U7X
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
739,798,202
bioavailability
ChemSpiderID
legal status
under clinical development
pregnancy category
routes of administration
Verifiedfields
verifiedrevid
477,236,922
hypernym
comment
Abagovomab is a mouse anti-idi ...... ent recurrence of the disease.
@en
L'abagovomab è un anticorpo mo ...... re la recidiva della malattia.
@it
أباغوفوماب هو جسم مضاد وحيد ال ...... قليل نمو هذا النوع من السرطان.
@ar
label
Abagovomab
@en
Abagovomab
@it
أباغوفوماب
@ar
